Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Review
DOI: 10.54448/mdnt22203
Submitted: 04-04-2022
Published: 04-04-2022

Investigation on the bisphosphonate and osseointegrated implants: a concise systematic review

ECUADENT CLINIC, Quito, Ecuador; UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil; UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
ECUDENT CLINIC, Lorenzo de Garaicoa s4-06 y Humberto Mora, Quito, Ecuador; UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil; UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil; UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
Bisphosphonate Osseointegration Dental implant Osteoporosis Osteonecrosis Complications

Abstract

The most common bone disorder found by implant dentists is osteoporosis, which is a systemic skeletal disorder associated with aging, which is characterized by loss of bone mass, making bones fragile and more susceptible to fractures. The World Health Organisation has defined osteoporosis as a bone mineral density level greater than 2.5 standard deviations below the mean of young normal women. After 60 years of age, a third of the population has this disorder, it occurs twice as often in women than in men. It is estimated that 1.3 million fractures and 133,000 all hip fractures occur every year as a result of osteoporosis. The aim of this study was to discuss aspects of the pharmacological action of Bisphosphonates (BP) and their influence on the bone tissue when associated with treatment with dental implants. There are several types of treatments that prevent or prevent the progression of osteoporosis. So, BP, such as alendronate, are inhibitors of bone resorption. Act as controlling the development of osteoporosis by increasing the process of bone density and decreasing its reabsorption, often acting as supporting the process of osseointegration of dental implants.

Metrics

Metrics Loading ...

References

  1. Sher J, Kirkham-Ali K, Luo JD, Miller C, Sharma D. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review. J Oral Implantol. 2021 Jun 1;47(3):249-268. doi: 10.1563/aaid-joi-D-19-00351. PMID: 32699903.
  2. Romero-Ruiz MM, Romero-Serrano M, Serrano-González A, Serrera-Figallo MÁ, Gutiérrez-Pérez JL, Torres-Lagares D. Proposal for a preventive protocol for medication-related osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal. 2021 May 1;26(3):e314-e326. doi: 10.4317/medoral.24197. PMID: 33037798; PMCID: PMC8141321.
  3. Seki K, Namaki S, Kamimoto A, Hagiwara Y. Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review. J Oral Implantol. 2021 Dec 1;47(6):502-510. doi: 10.1563/aaid-joi-D-19-00385. PMID: 33270837.
  4. Touyz LZG, Afrashtehfar KI. Implications of bisphosphonate calcium ion depletion interfering with desmosome epithelial seal in osseointegrated implants and pressure ulcers. Med Hypotheses. 2017 Sep;107:22-25. doi: 10.1016/j.mehy.2017.07.013. Epub 2017 Jul 18.
  5. Pogrel MA, Ruggiero SL. Previously successful dental implants can fail when patients commence anti-resorptive therapy-a case series. Int J Oral Maxillofac Surg. 2018 Feb;47(2):220-222. doi: 10.1016/j.ijom.2017.07.012. Epub 2017 Aug 10.
  6. Chrcanovic BR, Albrektsson T, Wennerberg A. Bisphosphonates and dental implants: A meta-analysis. Quintessence Int. 2016 Apr;47(4):329-42. doi: 10.3290/j.qi.a35523.
  7. Basso FG, Pansani TN, Soares DG, Cardoso LM, Hebling J, de Souza Costa CA. Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces. Clin Oral Investig. 2018 Mar;22(2):893-900. doi: 10.1007/s00784-017-2167-2. Epub 2017 Jul 8.
  8. Gelazius R, Poskevicius L, Sakavicius D, Grimuta V, Juodzbalys G. Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review. J Oral Maxillofac Res. 2018 Sep 30;9(3):e2. doi: 10.5037/jomr.2018.9302. eCollection 2018 Jul-Sep.
  9. Camargo, E. P.; Minosso, M.; Lopes, L. C. Caracterização do Uso de Alendronato de Sódio no Tratamento de Osteoporose por Clínicos da Rede Privada de Duas Cidades do Interior de São Paulo. Rev. Ciênc. Farm. Básica Apl., v.28, n.1, p.77-83, 2007.
  10. Carvalho, P. S. P. et al. Principais Aspectos da Cirurgia Bucomaxilofacial no Paciente sob Terapia com Bifosfonatos. RFO UPF [online]. 2010, vol.15, n.2, pp. 183-189. ISSN 1413-4012.
  11. Duarte, P. M.; Nociti Júnior, F. H. Impacto da Deficiência de Estrógeno e suas Terapias sobre o Tecido Ósseo ao Redor de Implantes de Titânio e na Periodontite Induzida em Ratas Ovariectomizadas. Tese (Doutorado) – Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba. Piracicaba, 2004. XVII, 131p.
  12. Embracher Filho, A. Projeto Colosso: Desenvolvimento de um sistema de implante osseointegrável. Da teoria a prática. Tese (Doutorado) - Faculdade de Odontologia de Araçatuba, UNESP, 2003.
  13. Ferreira Júnior, C. D; Casado, P. L.; Barboza, E. S. P. Osteonecrose Associada aos Bisfosfonatos na Odontologia. R. Periodontia. v.1, n.4, dez., 2007.
  14. Gegler A. et al. Bifosfonatos e Osteonecrose Maxilar: Revisão da Literatura e Relato de Dois Casos. Rev. Brasileira de Cancerologia 2006; 52(1):25-31.
  15. Ishii, J. H. Osteoporose e os Implantes Dentários. São Paulo, 2009. 24 p.
  16. Luize, D. S. et al. A Influência da Osteoporose na Implantodontia. Arquivos em Odontologia, Belo Horizonte, v.41, n.2, p.105-192, abr./jun. 2005.
  17. Martins, M. A. T.; et al. Osteonecrose dos Maxilares Associada ao Uso de Bifosfonatos: Importante Complicação do Tratamento Oncológico. Rev. Bras. Hematol Hemoter 2009; 31(1):41-46.
  18. Migliorati CA et al. O Tratamento de Pacientes com Osteonecrose Associada aos Bifosfonatos. Uma tomada de posição da Academia Americana de Medicina Oral. J American Dental Association 2006; 136(12).
  19. Misch CE. Implantes Dentais Contemporâneos. Rio de Janeiro: Elsevier. 2008, 3nd.
  20. WHO Scientific Group on the Prevention and Management of Osteoporosis (‎2000 : Geneva, Switzerland)‎. (‎2003)‎. Prevention and management of osteoporosis : report of a WHO scientific group. World Health Organization. https://apps.who.int/iris/handle/10665/42841
  21. Ourique SAM, Ito AY, Suarez OF. Osteoporose em Implantodontia: O Estado Atual da Questão. Rev. Bras. Implantodontia e Prótese sobre Implantes, 2005: 12(47/48): 237-45.
  22. Goiato MC, Santos DM, Rondon BCS, Moreno A, Baptista GT, Verri FR et al. Care Required When Using Bisphosphonates in Dental Surgical Practice. J. craniofac. surg. 2010; 21(6):1966-70.
  23. Chadha GK, Ahmadieh A, Kumar S, Sedghizaded PP. Osseointegration of dental osteonecrosis of the jaw in patients treated with bisphosphonates therapy: a systematic review. J. oral implantol. 2013;39(4):510-20.
  24. Mellado-Valero A, Ferrer-García JC, CalvoCatalá J, Labaig- Rueda C. Implant treatment in patients with osteoporosis. Med. oral patol. oral cir. bucal. 2010; 15:52-7.
  25. López-Cedrún JL, Sanromán JF, García A, Peñarrocha M, Feijoo JF, Limeres J, Diz P. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series. Br. j. oral maxillofac. surg. 2012;51(8):874-9.
  26. Kwon T-G, Lee C-O, Park J-W, Choi S-Y, Rijal G, Shin H-I. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin. oral implants res. 2012; 00:1- 9.
  27. Yip JK, Borrell LN, Cho SC, Francisco H, Tarnow DP. Association between oral bisphosphonate use and dental implant failure among middleaged women. J. clin. periodontol. 2012;39:408- 14.
  28. Memon S, Weltman RL, Katancik JA. Oral Bisphosphonates: Early Endosseous Dental Implant Success and Crestal Bone Changes. A Retrospective Study. Int. j. oral maxillofac. implants. 2012;279(5):1216-22.
  29. Abtahi J, Tengvall P, Aspenberg P. A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone. 2012;50(5):1148- 51.
  30. Jacobsen C, Metzler P, Rossle M, Obwegeser J, Zemann W, Gratz KW. Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin. oral investig. 2013;17:167-75.

How to Cite

Romero Urdiales, L. A., Yaguana Galarraga, D. A., & Manzini, R. (2022). Investigation on the bisphosphonate and osseointegrated implants: a concise systematic review. MedNEXT Journal of Medical and Health Sciences, 3(2). https://doi.org/10.54448/mdnt22203